{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T01:02:59Z","timestamp":1782435779119,"version":"3.54.5"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,11,14]],"date-time":"2020-11-14T00:00:00Z","timestamp":1605312000000},"content-version":"am","delay-in-days":318,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001677","name":"Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001677","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.antiviral.2019.104647","type":"journal-article","created":{"date-parts":[[2019,11,7]],"date-time":"2019-11-07T02:36:07Z","timestamp":1573094167000},"page":"104647","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Characterization of the dynamics of human cytomegalovirus resistance to antiviral drugs by ultra-deep sequencing"],"prefix":"10.1016","volume":"173","author":[{"given":"H\u00e9l\u00e8ne","family":"Guermouche","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Burrel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00e9lanie","family":"Mercier-Darty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Kofman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Rogier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Michel","family":"Pawlotsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Boutolleau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Rodriguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2019.104647_bib1","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1128\/jvi.70.3.1390-1395.1996","volume":"70","author":"Baldanti","year":"1996","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2019.104647_bib2","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.antiviral.2011.04.015","article-title":"Genotypic characterization of human cytomegalovirus UL97 phosphotransferase natural polymorphism in the era of ganciclovir and maribavir","volume":"91","author":"Boutolleau","year":"2011","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2019.104647_bib3","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.antiviral.2008.11.003","article-title":"Resistance pattern of cytomegalovirus (CMV) after oral valganciclovir therapy in transplant recipients at high-risk for CMV infection","volume":"81","author":"Boutolleau","year":"2009","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2019.104647_bib4","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1002\/rmv.1873","article-title":"Human cytomegalovirus antiviral drug resistance in hematopoietic stem cell transplantation: current state of the art","volume":"26","author":"Campos","year":"2016","journal-title":"Rev. Med. Virol."},{"key":"10.1016\/j.antiviral.2019.104647_bib5","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1097\/QCO.0000000000000170","article-title":"Approach to drug-resistant cytomegalovirus in transplant recipients","volume":"28","author":"Chou","year":"2015","journal-title":"Curr. Opin. Infect. Dis."},{"key":"10.1016\/j.antiviral.2019.104647_bib6","doi-asserted-by":"crossref","first-page":"4697","DOI":"10.1128\/AAC.03214-14","article-title":"Improved detection of emerging drug-resistant mutant cytomegalovirus subpopulations by deep sequencing","volume":"58","author":"Chou","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2019.104647_bib7","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1086\/518514","article-title":"Cytomegalovirus UL97 kinase mutations that confer maribavir resistance","volume":"196","author":"Chou","year":"2007","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2019.104647_bib8","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1097\/QCO.0000000000000170","article-title":"Approach to drug-resistant cytomegalovirus in transplant recipients","volume":"28","author":"Chou","year":"2015","journal-title":"Curr. Opin. Infect. Dis."},{"key":"10.1016\/j.antiviral.2019.104647_bib9","doi-asserted-by":"crossref","first-page":"5927","DOI":"10.1128\/JVI.72.7.5927-5936.1998","article-title":"Characterization of drug resistance-associated mutations in the human cytomegalovirus DNA polymerase gene by using recombinant mutant viruses generated from overlapping DNA fragments","volume":"72","author":"Cihlar","year":"1998","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2019.104647_bib10","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S1386-6532(00)00165-7","article-title":"Progress in understanding cytomegalovirus drug resistance","volume":"21","author":"Emery","year":"2001","journal-title":"J. Clin. Virol. : Off. Publ. Pan Am. Soc. Clin. Virol.."},{"key":"10.1016\/j.antiviral.2019.104647_bib11","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.jcv.2015.06.090","article-title":"Identification of newly detected, drug-related HCMV UL97- and UL54-mutations using a modified plaque reduction assay","volume":"69","author":"Fischer","year":"2015","journal-title":"J. Clin. Virol. : Off. Publ. Pan Am. Soc. Clin. Virol."},{"key":"10.1016\/j.antiviral.2019.104647_bib12","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.jcv.2016.04.017","article-title":"Contribution of next generation sequencing to early detection of cytomegalovirus UL97 emerging mutants and viral subpopulations analysis in kidney transplant recipients","volume":"80","author":"Garrigue","year":"2016","journal-title":"J. Clin. Virol. : Off. Publ. Pan Am. Soc. Clin. Virol."},{"key":"10.1016\/j.antiviral.2019.104647_bib13","doi-asserted-by":"crossref","first-page":"7195","DOI":"10.1128\/JVI.00475-10","article-title":"Deep sequencing reveals highly complex dynamics of human cytomegalovirus genotypes in transplant patients over time","volume":"84","author":"Gorzer","year":"2010","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2019.104647_bib14","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.3389\/fmicb.2016.01317","article-title":"Detection of low frequency multi-drug resistance and novel putative maribavir resistance in immunocompromised pediatric patients with cytomegalovirus","volume":"7","author":"Houldcroft","year":"2016","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.antiviral.2019.104647_bib15","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1038\/hdy.2016.58","article-title":"On the importance of skewed offspring distributions and background selection in virus population genetics","volume":"117","author":"Irwin","year":"2016","journal-title":"Heredity"},{"key":"10.1016\/j.antiviral.2019.104647_bib16","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1111\/j.1600-6143.2007.02133.x","article-title":"Improvement in long-term renal graft survival due to CMV prophylaxis with oral ganciclovir: results of a randomized clinical trial","volume":"8","author":"Kliem","year":"2008","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.antiviral.2019.104647_bib17","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1111\/tid.12007","article-title":"Everolimus is associated with a reduced incidence of cytomegalovirus infection following de novo cardiac transplantation","volume":"15","author":"Kobashigawa","year":"2013","journal-title":"Transpl. Infect. Dis. : Off. J. Transpl. Soc.."},{"issue":"4","key":"10.1016\/j.antiviral.2019.104647_bib32","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1097\/TP.0b013e31829df29d","article-title":"Updated international consensus guidelines on the management of cytomegalovirus in solid-organ transplantation","volume":"96","author":"Kotton","year":"2013","journal-title":"Transplantation"},{"key":"10.1016\/j.antiviral.2019.104647_bib18","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1097\/00007890-199911150-00010","article-title":"The impact of ganciclovir-resistant cytomegalovirus infection after lung transplantation","volume":"68","author":"Kruger","year":"1999","journal-title":"Transplantation"},{"key":"10.1016\/j.antiviral.2019.104647_bib19","series-title":"Ganciclovir-resistant Cytomegalovirus in Organ Transplant Recipients. Clinical Infectious Diseases","first-page":"866","volume":"vol. 35","author":"Limaye","year":"2002"},{"key":"10.1016\/j.antiviral.2019.104647_bib20","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/S0140-6736(00)02607-6","article-title":"Emergence of ganciclovir-resistant cytomegalovirus disease among recipients of solid-organ transplants","volume":"356","author":"Limaye","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.antiviral.2019.104647_bib21","series-title":"Definitions of Cytomegalovirus Infection and Disease in Transplant Patients for Use in Clinical Trials. Clinical Infectious Diseases","first-page":"87","article-title":"Disease definitions working group of the cytomegalovirus drug development, F","volume":"vol. 64","author":"Ljungman","year":"2017"},{"key":"10.1016\/j.antiviral.2019.104647_bib22","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1128\/CMR.00009-10","article-title":"Antiviral drug resistance of human cytomegalovirus","volume":"23","author":"Lurain","year":"2010","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.antiviral.2019.104647_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1386-6532(01)00160-3","article-title":"Variations in the cytomegalovirus DNA polymerase and phosphotransferase genes in relation to foscarnet and ganciclovir sensitivity","volume":"23","author":"Mousavi-Jazi","year":"2001","journal-title":"J. Clin. Virol. : Off. Publ. Pan Am. Soc. Clin. Virol."},{"key":"10.1016\/j.antiviral.2019.104647_bib24","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1093\/bioinformatics\/btr627","article-title":"QuRe: software for viral quasispecies reconstruction from next-generation sequencing data","volume":"28","author":"Prosperi","year":"2012","journal-title":"Bioinformatics"},{"key":"10.1016\/j.antiviral.2019.104647_bib25","doi-asserted-by":"crossref","first-page":"260","DOI":"10.3947\/ic.2013.45.3.260","article-title":"Cytomegalovirus infections in solid organ transplantation: a review","volume":"45","author":"Ramanan","year":"2013","journal-title":"Infect. Chemother."},{"key":"10.1016\/j.antiviral.2019.104647_bib26","doi-asserted-by":"crossref","first-page":"E4120","DOI":"10.1073\/pnas.1501880112","article-title":"Limits and patterns of cytomegalovirus genomic diversity in humans","volume":"112","author":"Renzette","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.antiviral.2019.104647_bib27","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1002\/hep.26383","article-title":"Characterization of the dynamics of hepatitis B virus resistance to adefovir by ultra-deep pyrosequencing","volume":"58","author":"Rodriguez","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.antiviral.2019.104647_bib28","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0127816","article-title":"HIV-1 coreceptor usage assessment by ultra-deep pyrosequencing and response to maraviroc","volume":"10","author":"Rodriguez","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.antiviral.2019.104647_bib29","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1111\/j.1399-3062.2000.020303.x","article-title":"Prevention of primary cytomegalovirus disease in organ transplant recipients with oral ganciclovir or oral acyclovir prophylaxis","volume":"2","author":"Rubin","year":"2000","journal-title":"Transpl. Infect. Dis. : Off. J. Transpl. Soc."},{"key":"10.1016\/j.antiviral.2019.104647_bib30","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1023\/A:1018839320383","article-title":"Oral ganciclovir usage for cytomegalovirus prophylaxis in organ transplant recipients: is emergence of resistance imminent?","volume":"43","author":"Singh","year":"1998","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.antiviral.2019.104647_bib31","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1111\/tid.12537","article-title":"Ganciclovir-resistant cytomegalovirus infection in solid organ transplant recipients: a single-center retrospective cohort study","volume":"18","author":"Young","year":"2016","journal-title":"Transpl. Infect. Dis. : Off. J. Transpl. Soc."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354219302049?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354219302049?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T12:29:53Z","timestamp":1759062593000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354219302049"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":32,"alternative-id":["S0166354219302049"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2019.104647","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Characterization of the dynamics of human cytomegalovirus resistance to antiviral drugs by ultra-deep sequencing","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2019.104647","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"104647"}}